Huons Global Co. Ltd (084110) - Net Assets
Based on the latest financial reports, Huons Global Co. Ltd (084110) has net assets worth ₩1.04 Trillion KRW (≈ $701.94 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩1.47 Trillion ≈ $998.36 Million USD) and total liabilities (₩437.39 Billion ≈ $296.42 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Huons Global Co. Ltd (084110) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩1.04 Trillion |
| % of Total Assets | 70.31% |
| Annual Growth Rate | 19.21% |
| 5-Year Change | 102.89% |
| 10-Year Change | 241.22% |
| Growth Volatility | 42.93 |
Huons Global Co. Ltd - Net Assets Trend (2010–2025)
This chart illustrates how Huons Global Co. Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 084110 current and non-current assets for the complete picture of this company's asset base.
Annual Net Assets for Huons Global Co. Ltd (2010–2025)
The table below shows the annual net assets of Huons Global Co. Ltd from 2010 to 2025. For live valuation and market cap data, see market cap of Huons Global Co. Ltd.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩1.09 Trillion ≈ $739.51 Million |
+109.81% |
| 2024-12-31 | ₩520.11 Billion ≈ $352.47 Million |
-42.89% |
| 2023-12-31 | ₩910.68 Billion ≈ $617.15 Million |
+96.13% |
| 2022-12-31 | ₩464.32 Billion ≈ $314.66 Million |
-13.67% |
| 2021-12-31 | ₩537.84 Billion ≈ $364.49 Million |
+30.28% |
| 2020-12-31 | ₩412.83 Billion ≈ $279.77 Million |
+9.06% |
| 2019-12-31 | ₩378.53 Billion ≈ $256.52 Million |
+4.50% |
| 2018-12-31 | ₩362.21 Billion ≈ $245.47 Million |
+6.18% |
| 2017-12-31 | ₩341.14 Billion ≈ $231.19 Million |
+6.67% |
| 2016-12-31 | ₩319.80 Billion ≈ $216.72 Million |
+89.30% |
| 2015-12-31 | ₩168.94 Billion ≈ $114.49 Million |
-10.32% |
| 2014-12-31 | ₩188.38 Billion ≈ $127.66 Million |
+50.42% |
| 2013-12-31 | ₩125.24 Billion ≈ $84.87 Million |
+34.79% |
| 2012-12-31 | ₩92.92 Billion ≈ $62.97 Million |
+18.85% |
| 2010-12-31 | ₩78.18 Billion ≈ $52.98 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Huons Global Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 23257703874000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩232.58 Billion | 42.54% |
| Other Components | ₩314.14 Billion | 57.46% |
| Total Equity | ₩546.71 Billion | 100.00% |
Huons Global Co. Ltd Competitors by Market Cap
The table below lists competitors of Huons Global Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Duta Pertiwi Tbk
JK:DUTI
|
$463.96 Million |
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
$464.06 Million |
|
Texmaco Rail & Engineering Limited
NSE:TEXRAIL
|
$464.08 Million |
|
Diamond Hill Investment Group Inc
NASDAQ:DHIL
|
$464.19 Million |
|
NIIT LEARNING SYSTEMS LTD
NSE:NIITMTS
|
$463.86 Million |
|
Minto Apartment Real Estate Investment Trust
TO:MI-UN
|
$463.75 Million |
|
Malteries Franco-Belges Société Anonyme
PA:MALT
|
$463.75 Million |
|
Changsha Tongcheng Holdings Co Ltd
SHE:000419
|
$463.74 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Huons Global Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 520,108,833,800 to 546,713,333,400, a change of 26,604,499,600 (5.1%).
- Net income of 28,838,245,240 contributed positively to equity growth.
- Dividend payments of 25,607,958,900 reduced retained earnings.
- Share repurchases of 17,506,840,050 reduced equity.
- New share issuances of 9,190,015,080 increased equity.
- Other factors increased equity by 31,691,038,230.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩28.84 Billion | +5.27% |
| Dividends Paid | ₩25.61 Billion | -4.68% |
| Share Repurchases | ₩17.51 Billion | -3.2% |
| Share Issuances | ₩9.19 Billion | +1.68% |
| Other Changes | ₩31.69 Billion | +5.8% |
| Total Change | ₩- | 5.12% |
Book Value vs Market Value Analysis
This analysis compares Huons Global Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.41x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.48x to 1.41x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩25442.54 | ₩63100.00 | x |
| 2017-12-31 | ₩27148.39 | ₩63100.00 | x |
| 2018-12-31 | ₩28815.94 | ₩63100.00 | x |
| 2019-12-31 | ₩30122.15 | ₩63100.00 | x |
| 2020-12-31 | ₩33068.87 | ₩63100.00 | x |
| 2021-12-31 | ₩41257.72 | ₩63100.00 | x |
| 2022-12-31 | ₩37909.32 | ₩63100.00 | x |
| 2023-12-31 | ₩40971.78 | ₩63100.00 | x |
| 2024-12-31 | ₩42701.80 | ₩63100.00 | x |
| 2025-12-31 | ₩44886.07 | ₩63100.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Huons Global Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.27%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.40%
- • Asset Turnover: 0.54x
- • Equity Multiplier: 2.85x
- Recent ROE (5.27%) is below the historical average (18.23%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 7.55% | 4.92% | 0.73x | 2.10x | ₩-2.16 Billion |
| 2013 | 15.17% | 10.99% | 0.77x | 1.80x | ₩5.93 Billion |
| 2014 | 13.69% | 11.48% | 0.72x | 1.66x | ₩5.64 Billion |
| 2015 | 19.17% | 49.48% | 0.21x | 1.86x | ₩15.49 Billion |
| 2016 | 160.93% | 314.36% | 0.29x | 1.74x | ₩482.66 Billion |
| 2017 | 7.52% | 7.92% | 0.53x | 1.79x | ₩-8.46 Billion |
| 2018 | 8.13% | 7.78% | 0.56x | 1.86x | ₩-6.77 Billion |
| 2019 | 7.04% | 5.93% | 0.61x | 1.96x | ₩-11.20 Billion |
| 2020 | 10.34% | 8.16% | 0.55x | 2.30x | ₩1.41 Billion |
| 2021 | 0.74% | 0.70% | 0.45x | 2.39x | ₩-49.79 Billion |
| 2022 | -12.98% | -9.07% | 0.53x | 2.68x | ₩-106.69 Billion |
| 2023 | 7.65% | 5.06% | 0.58x | 2.63x | ₩-11.80 Billion |
| 2024 | 4.96% | 3.17% | 0.58x | 2.70x | ₩-26.22 Billion |
| 2025 | 5.27% | 3.40% | 0.54x | 2.85x | ₩-25.83 Billion |
Industry Comparison
This section compares Huons Global Co. Ltd's net assets metrics with peer companies in the Pharmaceuticals industry.
Industry Context
- Industry: Pharmaceuticals
- Average net assets among peers: $76,340,880,510
- Average return on equity (ROE) among peers: -0.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Huons Global Co. Ltd (084110) | ₩1.04 Trillion | 7.55% | 0.42x | $463.90 Million |
| Sam Chun Dang Pharm. Co. Ltd (000250) | $86.63 Billion | 1.55% | 0.41x | $6.03 Billion |
| DongKoo Bio&Pharma Co. Ltd (006620) | $102.11 Billion | 6.48% | 0.69x | $33.52 Million |
| NatureCell Co.Ltd (007390) | $-16.60 Million | 0.00% | 0.00x | $688.81 Million |
| Sam-A Pharm. Co. Ltd (009300) | $79.92 Billion | 4.39% | 0.39x | $68.66 Million |
| Kyung Dong Pharmaceutical Co. Ltd (011040) | $150.62 Billion | 13.47% | 0.23x | $89.89 Million |
| WooGene B&G Co. Ltd (018620) | $22.14 Billion | 0.79% | 1.63x | $13.13 Million |
| Oscotec Inc (039200) | $94.72 Billion | -25.63% | 0.40x | $990.30 Million |
| EstechPharma Co. Ltd (041910) | $115.63 Billion | 3.31% | 0.05x | $59.21 Million |
| Komipharm International Co. Ltd (041960) | $76.13 Billion | -8.60% | 0.75x | $380.81 Million |
| Eagle Veterinary Technology Co.Ltd (044960) | $35.53 Billion | 3.47% | 0.29x | $34.35 Million |
About Huons Global Co. Ltd
Huons Global Co., Ltd. provides medical solutions for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and inj… Read more